S‐Cysteinylated Transthyretin in Cerebrospinal Fluid as a Biomarker of Specimen Integrity

Abstract Background Currently there is no way to determine if archived cerebrospinal fluid (CSF) specimens have been properly handled and can be considered suitable for research purposes. Transthyretin (TTR) is abundant in CSF and undergoes a redox reaction that shifts its native proteoform into an S‐cysteinylated form. This reaction proceeds spontaneously ex vivo when CSF is thawed, but ceases at storage temperatures of ‐80°C. The relative abundance of these TTR proteoforms can be measured using dilute‐and‐shoot, intact protein liquid chromatography/mass spectrometry (LC/MS). Here we report that the spontaneous ex vivo changes in TTR S‐cysteinylation that occur when CSF is in the thawed state are systematic and substantial enough to potentially qualify the relative abundance of S‐cysteinylated TTR as an endogenous marker capable of tracking specimen integrity. Method Twelve CSF samples that were recovered postmortem were provided by Banner Sun Health Research Institute. The specimens were from patients diagnosed with Alzheimer’s or Parkinson’s disease or deemed by a pathologist as neurologically normal. A 1:2 dilution of 10 µL of CSF with 0.1% trifluoroacetic acid was directly injected onto a capillary LC system through a protein captrap (via a 10‐minute run), then into a time‐of‐flight mass spectrometer. Raw mass spectra were averaged over the TTR elution period. Following charge state deconvolution, the peak heights representing S‐cysteinylated TTR and native TTR were determined. Specimens were then incubated at 37°C for 24 hours to drive the ex vivo oxidation process to its conclusion and the LC/MS measurement process was repeated. Result The mean relative percentage of all initially measured CSF specimens was 23.1% (± 20% SD). Following 24 hours of incubation at 37°C, the mean relative percentage of S‐cysteinylated TTR increased to 86.0% (± 5.3% SD); paired t‐test p<0.0001 and ROC c‐statistic=0.99. Conclusion The dynamic range observed in the relative percentage of S‐cysteinylated TTR between nominally fresh and fully ex vivo‐oxidized CSF specimens was substantially greater than that observed in our previously developed ΔS‐Cys‐Albumin assay, which is used to forensically track the exposure of blood plasma and serum to thawed conditions. This suggests that a ΔS‐Cys‐TTR assay could find similar utility for archived CSF specimens.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.087617
Primary Topic
Fibroblast Growth Factor Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S‐Cysteinylated Transthyretin in Cerebrospinal Fluid as a Biomarker of Specimen Integrity

S. Kremer, Chad R. Borges
Alzheimer s & Dementia
Fibroblast Growth Factor Research
article

S‐Cysteinylated Transthyretin in Cerebrospinal Fluid as a Biomarker of Specimen Integrity

S. Kremer, Chad R. Borges
article en

Abstract

Abstract Background Currently there is no way to determine if archived cerebrospinal fluid (CSF) specimens have been properly handled and can be considered suitable for research purposes. Transthyretin (TTR) is abundant in CSF and undergoes a redox reaction that shifts its native proteoform into an S‐cysteinylated form. This reaction proceeds spontaneously ex vivo when CSF is thawed, but ceases at storage temperatures of ‐80°C. The relative abundance of these TTR proteoforms can be measured using dilute‐and‐shoot, intact protein liquid chromatography/mass spectrometry (LC/MS). Here we report that the spontaneous ex vivo changes in TTR S‐cysteinylation that occur when CSF is in the thawed state are systematic and substantial enough to potentially qualify the relative abundance of S‐cysteinylated TTR as an endogenous marker capable of tracking specimen integrity. Method Twelve CSF samples that were recovered postmortem were provided by Banner Sun Health Research Institute. The specimens were from patients diagnosed with Alzheimer’s or Parkinson’s disease or deemed by a pathologist as neurologically normal. A 1:2 dilution of 10 µL of CSF with 0.1% trifluoroacetic acid was directly injected onto a capillary LC system through a protein captrap (via a 10‐minute run), then into a time‐of‐flight mass spectrometer. Raw mass spectra were averaged over the TTR elution period. Following charge state deconvolution, the peak heights representing S‐cysteinylated TTR and native TTR were determined. Specimens were then incubated at 37°C for 24 hours to drive the ex vivo oxidation process to its conclusion and the LC/MS measurement process was repeated. Result The mean relative percentage of all initially measured CSF specimens was 23.1% (± 20% SD). Following 24 hours of incubation at 37°C, the mean relative percentage of S‐cysteinylated TTR increased to 86.0% (± 5.3% SD); paired t‐test p<0.0001 and ROC c‐statistic=0.99. Conclusion The dynamic range observed in the relative percentage of S‐cysteinylated TTR between nominally fresh and fully ex vivo‐oxidized CSF specimens was substantially greater than that observed in our previously developed ΔS‐Cys‐Albumin assay, which is used to forensically track the exposure of blood plasma and serum to thawed conditions. This suggests that a ΔS‐Cys‐TTR assay could find similar utility for archived CSF specimens.

Alzheimer s & DementiaVol. 20(S2)
Arizona State University (US)
Openalex Percentile: Top 78%
Fibroblast Growth Factor Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.